InvestorsHub Logo
icon url

EZLibra

09/06/12 8:21 PM

#90426 RE: Thurly #90423

Yes, in deed. It unmasks the blockers.

A Bavi infusion might, theoretically, stimulate immunostimulatory responses to other ps exposed problems such as RSV, HPV, HCV before they become systemic. Part and parcel of the platform IMO.

Anti ps is a humongous platform technology. Tommorow's ASCO Chicago is just an inkling.
icon url

biopharm

09/06/12 8:48 PM

#90428 RE: Thurly #90423

That could very well be true and I guess I am thinking too far aheah of the Bavi possibilities...or hopeful extended possibilities. I guess my next thought would be if this works as well as I hope....would it be possible if you had a some pretermined dosage of Bavituximab every 5 years or 10...etc just as precaution. My thinking is that many people get diagnosed too late ...but I should be hoping that their Imaging latest developments will be the solution to that (detecting a solid tumor cancer) 1 or 2 years before it can be seen or diagnosed from current standards.

The future looks very promising for Team Peregrine!
icon url

asmarterwookie

09/06/12 9:58 PM

#90435 RE: Thurly #90423

Thurly et al...King or Garnick stated that Macrophage and Dendritic cells have PS receptors. Wedbush or previous CC..forget but know I heard it. I believe.
Sorry could not get to CR project...from breast cancer you mentioned...always running....

wook